Evaluating the Combined Anticancer Response of Checkpoint Inhibitor Immunotherapy and FAP-Targeted Molecular Radiotherapy in Murine Models of Melanoma and Lung Cancer

Evaluating the Combined Anticancer Response of Checkpoint Inhibitor Immunotherapy and FAP-Targeted Molecular Radiotherapy in Murine Models of Melanoma and Lung Cancer

Immunotherapy has dramatically improved outcomes for some cancer patients; however, novel treatments are needed for more patients to achieve a long-lasting response. FAP-targeted molecular radiotherapy has shown efficacy in both preclinical and clinical models and has immunomodulatory effects. Here,...

Full description

Bibliographic Details
Main Authors: Kathleen M. Capaccione, Mikhail Doubrovin, Brian Braumuller, Dev Leibowitz, Nikunj Bhatt, Fatemeh Momen-Heravi, Andrei Molotkov, Michael Kissner, Kimberly Goldner, Mark Soffing, Alessandra Ali, Akiva Mintz
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
molecular targeted radiotherapy
immunotherapy
melanoma
lung cancer
Online Access:https://www.mdpi.com/2072-6694/14/19/4575

Internet

https://www.mdpi.com/2072-6694/14/19/4575

Similar Items